Profiles

Jeremy L. Jenkins

US Head Discovery Sciences, Novartis BioMedical Research

Verified email at novartis.com

Cited by 9245

cheminformatics phenotypic screening target prediction chemical biology

Bartek Rajwa

Purdue University

Verified email at purdue.edu

Cited by 7309

biodetection biosurveillance computational biology phenotypic screening bioinformatics

Selim Cellek

Professor Selim Cellek, Anglia Ruskin University

Verified email at anglia.ac.uk

Cited by 5621

fibrosis diabetic autonomic neuropathy phenotypic screening

Paul D. Andrews PhD

Director of Operations, National Phenotypic Screening Centre, University of Dundee

Verified email at dundee.ac.uk

Cited by 4575

Phenotypic Screening drug discovery chemical biology

Richard Novak

CEO, Unravel Biosciences

Verified email at unravel.bio

Cited by 4411

microfluidics phenotypic screening single cell analysis organs-on-chip therapeutics discovery

Jason R. Thomas

Novartis Biomedical Research

Verified email at novartis.com

Cited by 3872

Chemical Biology chemoproteomics phenotypic screening target identification elucidation of

Nicole E. Bodycombe

Principal Scientist, Pfizer

Verified email at Pfizer.com

Cited by 3619

Computational Chemical Biology Cheminformatics Bioinformatics Phenotypic Screening

Fabien Vincent

Pfizer

Verified email at pfizer.com

Cited by 3467

Phenotypic screening molecular pharmacology drug discovery

Brent Ryan

Group Leader, Research Lecturer, University of Oxford

Verified email at dpag.ox.ac.uk

Cited by 3232

Parkinson's Disease Mitophagy Phenotypic Screening Proteomics

Robert Everley

Senior Director of Chemical Biology, Frontier Medicines

Verified email at frontiermeds.com

Cited by 3154

Proteomics Targeted Quantification Phenotypic Screening Protein Degradation Chemical Biology

1 - 10